INVO Fertility (IVF) Depreciation & Amortization (CF) (2011 - 2026)
INVO Fertility (IVF) posted quarterly Depreciation & Amortization (CF) of $142698.0 for Q1 2026, down 39.14% year-over-year from $234462.0 in Q1 2025, and up 4.36% quarter-over-quarter from $136741.0 in Q3 2025.
INVO Fertility (IVF) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends
INVO Fertility (IVF) has reported Depreciation & Amortization (CF) for 16 consecutive years, with $142698.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) fell 39.14% year-over-year to $142698.0; the TTM figure through Mar 2026 stood at $449175.0 (down 51.55% YoY), while the FY2024 annual figure was $919603.0, up 357.76% from the prior year.
- Depreciation & Amortization (CF) climbed to $142698.0 in Q1 2026 per IVF's latest filing, from $136741.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $234462.0 in Q1 2025 and bottomed at $15547.0 in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $117589.7 across 5 years, with a median of $139169.5 in 2023.
- Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) surged 1089.08% — and 2025, when it sank 40.68%.
- INVO Fertility's Depreciation & Amortization (CF) stood at $19940.0 in 2022, then jumped by 610.12% to $141598.0 in 2023, then jumped by 63.71% to $231810.0 in 2024, then plunged by 41.01% to $136741.0 in 2025, then increased by 4.36% to $142698.0 in 2026.
- Business Quant data shows IVF's Depreciation & Amortization (CF) at $142698.0 in Q1 2026, $136741.0 in Q3 2025, and $169736.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 123.80 Mn |
| 10 | INVO Fertility | 2.38 Mn | 2.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -20,713.00 |
| Jun 30, 2026 | -20,713.00 |
| Mar 31, 2026 | 142,698.00 |
| Mar 31, 2026 | 142,698.00 |
| Sep 30, 2025 | 136,741.00 |
| Sep 30, 2025 | 136,741.00 |
| Jun 30, 2025 | 169,736.00 |
| Jun 30, 2025 | 169,736.00 |
| Mar 31, 2025 | 234,462.00 |
| Mar 31, 2025 | 234,462.00 |
| Dec 31, 2024 | 231,810.00 |
| Dec 31, 2024 | 231,810.00 |
| Sep 30, 2024 | 230,495.00 |
| Sep 30, 2024 | 230,495.00 |
| Jun 30, 2024 | 230,338.00 |
| Jun 30, 2024 | 230,338.00 |
| Mar 31, 2024 | 226,960.00 |
| Mar 31, 2024 | 226,960.00 |
| Dec 31, 2023 | 141,598.00 |
| Dec 31, 2023 | 141,598.00 |